Bettina Schreiner
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 29, 2026
Localized PD-1 CAR T therapy reprograms neuroinflammation.
Journal: Cell
Published: September 07, 2025
Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy.
Journal: Clinical neurology and neurosurgery
Published: February 18, 2025
Aseptic meningoencephalitis during nusinersen therapy in a patient with type III spinal muscular atrophy: a case report.
Journal: Neuromuscular disorders : NMD
Published: February 02, 2025
Brain atrophy patterns in anti-IgLON5 disease.
Journal: Brain : a journal of neurology
Published: November 11, 2024
Acute leukoencephalopathy associated with daratumumab treatment in POEMS syndrome: a case report.
Journal: Frontiers in immunology
Published: June 19, 2024
Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy.
Journal: Open medicine (Warsaw, Poland)
Published: May 25, 2024
Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
Journal: Neurology
Published: April 26, 2024
Immune triggers preceding neuralgic amyotrophy.
Journal: European journal of neurology
Published: April 16, 2024
Last Updated: 09/26/2026